English
  1. Home
  2. Stocks
  3. Thyrocare Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Thyrocare Technologies Share Price Thyrocare Technologies

    Small Cap
    ₹619.3
    -6.8 (-1.09%)
    13 May, 2024 23:41 BSE: 539871 NSE: THYROCAREISIN: INE594H01019

    Start SIP in Thyrocare Technologies

    Start SIP

    Thyrocare Technologies Performance

    Day Range

    • Low 614
    • High 648
    ₹ 619

    52 Week Range

    • Low 448
    • High 723
    ₹ 619
    • Open Price630
    • Previous Close626
    • Volume89566

    Thyrocare Technologies Share Price

    • Over 1 Month -0.54%
    • Over 3 Month +7%
    • Over 6 Month +12.71%
    • Over 1 Year +32.91%

    Thyrocare Technologies Key Statistics

    P/E Ratio 50
    PEG Ratio -4.9
    Market Cap Cr 3,279
    Price to Book Ratio 6.1
    EPS 10.4
    Dividend 0
    Relative Strength Index 44.04
    Money Flow Index 71.89
    MACD Signal 1.38
    Average True Range 23.84
    Thyrocare Technologies Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 123136124125
    Operating Expenses Qtr Cr 9210090102
    Operating Profit Qtr Cr 31373323
    Depreciation Qtr Cr 11999
    Interest Qtr Cr 1111
    Tax Qtr Cr 6885
    Net Profit Qtr Cr 15201710
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 492
    Operating Expenses Annual Cr 374
    Operating Profit Annual in Cr 112
    Depreciation Cr 34
    Interest Annual Cr 2
    Tax Annual Cr 24
    Net Profit Annual Cr 57
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 120
    Cash from Investing Activity Annual Cr -32
    Cash from Financing Annual Activity Cr -88
    Net Cash Flow Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 521
    Fixed Assets Annual Cr 157
    Total Non Current Assets Annual Cr 377
    Total Current Assets Annual Cr 235
    Total Assets Annual Cr 612
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 98
    ROE Annual % 11
    ROCE Annual % 15
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 24
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 135148135136
    Operating Expenses Qtr Cr 103110101111
    Operating Profit Qtr Cr 32383425
    Depreciation Qtr Cr 13111011
    Interest Qtr Cr 1111
    Tax Qtr Cr 5885
    Net Profit Qtr Cr 15201713
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 535
    Operating Expenses Annual Cr 407
    Operating Profit Annual in Cr 120
    Depreciation Cr 39
    Interest Annual Cr 2
    Tax Annual Cr 24
    Net Profit Annual Cr 64
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 129
    Cash from Investing Activity Annual Cr -39
    Cash from Financing Annual Activity Cr -86
    Net Cash Flow Annual Cr 4
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 534
    Fixed Assets Annual Cr 195
    Total Non Current Assets Annual Cr 360
    Total Current Assets Annual Cr 273
    Total Assets Annual Cr 633
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 101
    ROE Annual % 12
    ROCE Annual % 16
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 24
    Sign Up to Know More
    Invest in Thyrocare Technologies

    Thyrocare Technologies Technicals

    EMA & SMA

    Current Price
    ₹619.3
    -6.8 (-1.09%)
    pointer
    • Bullish Moving Average
    • ___
    • 3
    • Bearish Moving Average
    • ___
    • 13
    • 20 Day
    • ₹629.69
    • 50 Day
    • ₹628.73
    • 100 Day
    • ₹620.60
    • 200 Day
    • ₹604.20
    • 20 Day
    • ₹633.98
    • 50 Day
    • ₹634.00
    • 100 Day
    • ₹632.66
    • 200 Day
    • ₹597.49

    Thyrocare Technologies Resistance and Support

    PIVOT
    ₹627.
    Resistance
    First Resistance 639.95
    Second Resistance 660.60
    Third Resistance 673.55
    RSI 44.04
    MFI 71.89
    MACD Single Line 1.38
    MACD -1.48
    Support
    First Resistance 606.35
    Second Resistance 593.40
    Third Resistance 572.75

    Thyrocare Technologies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 93,614 2,135,335 22.81
    Week 269,447 17,126,039 63.56
    1 Month 126,952 8,268,408 65.13
    6 Month 125,597 5,437,107 43.29

    Thyrocare Technologies Result Highlights

    Thyrocare Technologies Synopsis

    NSE-Medical-Services

    Thyrocare Tech. is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 486.46 Cr. and Equity Capital is Rs. 52.93 Cr. for the Year ended 31/03/2023. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.
    Market Cap 3,279
    Sales 508
    Shares in Float 1.54
    No of funds 51
    Yield 2.75
    Book Value 6.34
    U/D Vol ratio 3.1
    LTDebt / Equity
    Alpha 0.06
    Beta 0.94

    Thyrocare Technologies

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 71.11%71.11%71.14%71.14%
    Mutual Funds 12.94%12.47%11.91%12.04%
    Insurance Companies 1.08%1.08%1.08%1.08%
    Foreign Portfolio Investors 2.9%3.35%3.46%3.44%
    Financial Institutions/ Banks
    Individual Investors 8.48%9.14%9.66%9.42%
    Others 3.49%2.85%2.75%2.88%

    Thyrocare Technologies Management

    Name Designation
    Mr. Rahul Guha Managing Director & CEO
    Mr. Dharmil Sheth Non Executive Director
    Mr. Hardik Dedhia Non Executive Director
    Mr. Dhaval Shah Non Executive Director
    Mr. Gopalkrishna Shivram Hegde Independent Director
    Dr. Indumati Gopinathan Independent Director
    Dr. Neetin S Desai Independent Director

    Thyrocare Technologies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Thyrocare Technologies Corporate Action

    Date Purpose Remarks
    2024-05-14 Audited Results & Final Dividend
    2024-02-01 Quarterly Results
    2023-10-31 Quarterly Results
    2023-08-01 Quarterly Results
    2023-05-23 Audited Results
    Date Purpose Remarks
    2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
    2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend

    Thyrocare Technologies MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 45,749
    Quant Small Cap Fund Growth 20,164
    ICICI Prudential India Opportunities Fund Regular Growth 19,072
    Nippon India Pharma Fund - Growth 7,133
    ICICI Prudential Innovation Fund Regular Growth 4,453

    Thyrocare Technologies FAQs

    What is Share Price of Thyrocare Technologies ?

    Thyrocare Technologies share price is ₹619 As on 13 May, 2024 | 23:27

    What is the Market Cap of Thyrocare Technologies ?

    The Market Cap of Thyrocare Technologies is ₹3279.4 Cr As on 13 May, 2024 | 23:27

    What is the P/E ratio of Thyrocare Technologies ?

    The P/E ratio of Thyrocare Technologies is 50 As on 13 May, 2024 | 23:27

    What is the PB ratio of Thyrocare Technologies ?

    The PB ratio of Thyrocare Technologies is 6.1 As on 13 May, 2024 | 23:27

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.